Portfolia — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Nalu Bio develops an AI-powered drug discovery platform targeting the endocannabinoid system to create therapeutics for inflammatory, immune, and metabolic diseases.
AI & Machine LearningBiotechHealthtechMedical DevicesSan Francisco, US
Caitlyn Krebs(Co-founder + CEO)Phyllis Whiteley(Co-founder + Board Member)Randall Ussery(Co-founder + Board Member)Phyllis E. Whiteley(Executive Officer, Director)Howard Goodwin(Director)Randall S. Ussery(Director)
Nature Coatings makes BioBlack, a bio-based black pigment produced from certified wood waste that replaces fossil-derived carbon black.
Advanced ManufacturingCleantechClimate TechNew MaterialsLas Vegas, US
James Palmer(Director)S. Jane Palmer(Jane is the chief executive officer of the corporation.)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.